Profile
ABCM NVO VRTX REGN SGEN ARGX
Company Name Abcam plc Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $473.53B $116.14B $79.76B $43.15B $36.58B
Employees 1.76K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Mr. Alan Thomas Hirzel BS, M.B.A., M.S. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABCM NVO VRTX REGN SGEN ARGX
Quant Rating Score 3 3 4 3 1
Quant Rating Neutral Neutral Buy Neutral Strong Sell
Trading
ABCM NVO VRTX REGN SGEN ARGX
Last Close $23.99 $105.06 $450.97 $738 $228.74 $605.92
High 52 $23.99 $146.91 $516.74 $1201.76 $228.74 $605.92
Low 52 $23.99 $101.74 $392.81 $738 $228.74 $356.01
Price vs. 52 Week High 0 % -28.49 % -12.73 % -38.59 % 0 % 0 %
Price vs. 52 Week Low 0 % 3.26 % 14.81 % 0 % 0 % 70.2 %
Total Return
ABCM NVO VRTX REGN SGEN ARGX
1 Month Return 0 % -9.23 % -4.06 % -21.61 % 0 % 8.6 %
3 Month Return 0 % -23.3 % -6.29 % -38.45 % 0 % 17.27 %
6 Month Return 0 % -22.5 % 0.04 % -24.74 % 0 % 67.84 %
9 Month Return 0 % -14.9 % 4.85 % -24.79 % 0 % 47.96 %
YTD Return 0 % 1.56 % 10.83 % -15.97 % 0 % 59.27 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.32 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) 0.43 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) -294.12 % 46.6 % - - - -
Growth
ABCM NVO VRTX REGN SGEN ARGX
Asset Growth 7.15 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 20.44 % 32.32 % 9.25 % 6.49 % 22.93 % 190.7 %
Revenue Growth 14.68 % 31.26 % 10.17 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year 27.5 % 90.51 % 59.87 % 55.67 % 91.84 % 2074.24 %
Revenue 5 Year 39.57 % 124.2 % 218.58 % 110.3 % 215.48 % 3040.37 %
Revenue 10 Year 155.91 % 66.11 % 608.27 % 549.62 % 494.04 % 9013.37 %
EBIT Growth -243.66 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Net Income Growth -293.18 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -162.32 % 106.79 % 34.59 % 13.48 % -764.83 % 63.97 %
Net Income 5 Yeari Growth Per Share -112.3 % 133.86 % 70.33 % 74.02 % -276.93 % -143.56 %
Net Income 10 Yeari Growth Per Share -122.5 % 98.61 % 809.6 % 871.12 % -624.16 % -857.4 %
Operating Income Growth -243.66 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -54.37 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -58.25 % 118.29 % 9.63 % 76.95 % -148.34 % 21.62 %
Operating 5 Year CFG -59.2 % 163.51 % 174.78 % 125.17 % -195.86 % -329.48 %
Operating 10 Year CFG -37.07 % 150.92 % 6084.35 % 713.56 % -2622.09 % -1280.79 %
EPS Growth -295.79 % 52.28 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth -293.75 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share 10.89 % 29 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share 32.55 % 75.22 % 104.06 % 137.56 % 33.92 % 93.95 %
Share Holder 5 Year Equity Growth Per Share 85.99 % 121.9 % 291.14 % 219.1 % 220.81 % 318.67 %
Share Holder 10 Year Equity Growth Per Share 269.11 % 49.62 % 1030.79 % 1286.9 % 691.19 % 3655.65 %
Dividend Per Share Growth 0.09 % 26.89 % - - - -
Dividend 3 Year Growth Per Share -8.35 % 64.4 % - - - -
Dividend 5 Year Growth Per Share 1.8 % 80.03 % - - - -
Dividend 10 Year Growth Per Share 72.85 % 95.44 % - - - -
Debt Growth -2.53 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -506.45 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ABCM NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 74.79 % 84.66 % 86.1 % 83.54 % 72.37 % 86.82 %
Return on Assets TTM -0.8 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -1.23 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -1.19 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 54.49 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 152.94 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -2.82 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM 12.82 % 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM 4.01 3.4 6.06 2.27 1.98 3.45
Payables Turnover TTM 5.77 1.72 3.73 4.58 1.54 1.06
Inventory Turnover TTM 1.34 1.09 1.37 0.76 0.65 0.91
Fixed Asset Turnover TTM 226.49 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 34.23 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM 0.13 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -0.06 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 38.92 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM 7.93 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM -43.9 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM 12.82 % 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -350.39 50.51 -99.79 23.61 -141.85 -173.18
Price To Operating Cash Flows Ratio TTM 152.86 28.29 -138.08 18.78 -203.89 -250.16
Price Cash Flow Ratio TTM 152.86 28.29 -138.08 18.78 -203.89 -250.16
Income Statement (TTM)
ABCM NVO VRTX REGN SGEN ARGX
Revenue $0.36B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $0.27B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 74.79% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $0.04B $114.63B $4.61B $4.65B $-0.62B $-0.22B
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -0.04 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ABCM NVO VRTX REGN SGEN ARGX
Long Term Debt $0.1B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.33B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.73B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.22B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $1.06B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ABCM NVO VRTX REGN SGEN ARGX
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $-0.01B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $-0.03B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $0.03B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0.04B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.3
ABCL AbCellera Biologics Inc. 2.76
ABEO Abeona Therapeutics Inc. 5.98
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.37
ABSI Absci Corporation 2.56
ABUS Arbutus Biopharma Corporation 3.51
ABVC ABVC BioPharma, Inc. 0.5488
ABVX Abivax SA American Depositary Shares 8.78
ACAD ACADIA Pharmaceuticals Inc. 16.37
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 0.9
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.06
ACHV Achieve Life Sciences, Inc. 4.29
ACIU AC Immune SA 3.38
ACLX Arcellx, Inc. 90.44
ACRV Acrivon Therapeutics, Inc. Common Stock 6.55
ACST Acasti Pharma Inc. 3.37
ACXP Acurx Pharmaceuticals, Inc. 1.35
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 137.96
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 35.28
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 56.84
MNA IQ Merger Arbitrage ETF 6.85 32.8
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 74.95
FPXI First Trust International Equity Opportunities ETF 0.45 49.48
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 33.02
MRGR ProShares Merger ETF 3.16608 42.1301
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 26.24
VINEX Vanguard International Explorer Fund Investor Shares 0.22 17.16
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 87.68
VGHCX Vanguard Health Care Fund Investor Shares 0.36 207.89
BMED BlackRock Future Health ETF 1.68229 25.3094
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 22.64
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 6.323
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 6.57625
DFIC Dimensional International Core Equity 2 ETF 0.00052105 26.46
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 6.576
CTRU ARK Transparency ETF 0.96 12.897
Unlock